06.03.2025 |
Management Team, News

BioStock interview with CEO John Glasspool on VMX-C001 at BioCapital Europe

Related items

24.02.2026

News, Scientific publications

VarmX announces publication of sensitive coagulation assays to assess restoration of coagulation using VMX-C001 in the presence of Factor Xa inhibitors
Key Highlights The collaborative study with Coagulation Profile BV, Maastricht University and Leiden University Medical Center has been accepted for…
Read more

08.01.2026

News

VarmX and Rentschler Biopharma partner to advance novel coagulation therapy toward Phase 3 and commercialization
VarmX and Rentschler Biopharma expand collaboration from early development to late‑stage and commercial manufacturing of VMX-C001 VMX‑C001 builds on strong…
Read more